Physician profile
Cara Hahs
NPI 1427031129
$550.21
in general payments reported to CMS, 2019-2025
13 companies · $282 in 2025
The $282 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $18.84 · 2022: $30.47 · 2023: $21.29 · 2024: $83.44 · 2025: $282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $192.95 | 2024-2025 | Molli, Spy-Phi System |
| Elucent Medical | $129.67 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $42.41 | 2020-2024 | Enhertu |
| Merck Sharp & Dohme LLC | $28.64 | 2019-2022 | |
| Amgen INC. | $25.23 | 2019 | |
| Hologic Sales and Service, LLC | $21.29 | 2023 | Trident Specimen Radiography System, Trunode, Localizer |
| Myriad Genetic Laboratories, INC. | $19.45 | 2024 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $17.54 | 2019 | |
| Daiichi Sankyo INC. | $15.15 | 2022 | |
| Janssen Biotech, INC. | $15.07 | 2019 | |
| Kyowa Kirin, INC. | $14.54 | 2019 | |
| Smith+Nephew, INC. | $14.22 | 2019 | |
| Focal Therapeutics, INC. | $14.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Hahs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.